Building the future of healthcare through science and innovation

Adedapo Adesokan's special interest are conceptualization and discovery of novel therapies for unmet clinical needs; from preclinical development to human trials leading to licensing. He bagged a MBBS from University of Ilorin, Nigeria followed by Masters in Clinical Pharmacology and PhD in Therapeutics from Glasgow University and completed his Residency in Emergency Medicine from NHS Sherwood Forest in England. He has been the CEO of Precismed Limited for 9 years and recently became the CEO/President of Famamedic Inc, Helix NJ, US. So far, he has invented 5 OTCs in the Chronic fatigue, Flu, Menopause & Anti-Aging spaces and has 4 medical devices with 4 repurposed synthetic medicines in the pipeline.

He presents his research works in International Pharmacology conferences round the world and has published 15 peer-reviewed articles on Emergency Medicine, Medicine, Clinical Pharmacology and Drug / Medical devices Discovery. His leadership philosophy is captured in a principle he developed and tagged 'TPPE-VPAH-ADAPT', which is the heart of his forthcoming book, 'The Making of the Physician-Entrepreneur Serial Biotech Inventor: The TPPE-VPAH-ADAPT Principle'.

Uchechi Osuagwu is the Executive Vice President and Chief Operating Officer of FamaMedic, leading the company's operational strategy, corporate execution, and organizational growth. She brings more than 15 years of executive leadership experience, including her previous role as a Partner at Ernst & Young (EY) in New York City. Her expertise spans enterprise transformation, operational excellence, corporate governance, technology strategy, cybersecurity, artificial intelligence, and enterprise risk management. She has extensive experience working with executives, boards, investors, regulators, and strategic stakeholders to drive transformation and build scalable organizations. At FamaMedic, she focuses on strengthening operational infrastructure, governance, compliance, partnerships, and commercialization readiness to support the company's long-term global growth.

Dr. Abdullahi O. Oseni is a board-certified interventional cardiologist with expertise in cardiovascular diseases and internal medicine. He specializes in complex, high-risk PCI, acute shock management, mechanical circulatory support, structural interventions, and cardiac critical care. He has completed advanced cardiovascular and interventional cardiology fellowships at leading U.S. medical institutions. His professional experience also includes extensive cardiovascular research, clinical trials, teaching, and academic presentations. He is committed to advancing cardiovascular care through clinical expertise, research, education, and evidence-based practice.